Serving To Educate Primary Care Clinicians On Metabolic Issues
Home
Subscribe
Feedback
Contact Us
Evidence Based Medicine
Medical Education
Metabolic Diseases
About Us
PCMG CME
PCMG Non-CME
Resources
Needs Survey
Commentaries
News
Survey
Nevada AFP CRM Pre Survey
Which of the following is true about screening for CKD in patients with diabetes?
[ Required ]
Checking eGFR and UACR is recommended since both independently predict CVD mortality
Only checking eGFR is recommended since it independently predicts CVD mortality
Only checking UACR is recommended since it independently predicts CVD mortality
Cystatin C and creatinine testing are preferred for initial CKD screening
What is the most appropriate action to take for a patient with T2D and CKD who is taking an SGLT-2 inhibitor and is admitted to the hospital for acute heart failure with acute kidney injury?
[ Required ]
Discontinue the SGLT-2 inhibitor since it likely caused the acute kidney injury
Hold the SGLT-2 inhibitor during hospitalization to avoid worsening kidney function
Continue the SGLT-2 inhibitor to lower mortality risk without excess risk of worsened kidney function
Increase the dose of the SGLT-2 inhibitor to maximize kidney-protective benefit in acute kidney injury
How confident do you feel in your answer to the previous question?
[ Required ]
Select...
Very confident
Confident
Somewhat confident
Not confident
Submit Survey